Beatrice Mahé

4.8k total citations
112 papers, 2.8k citations indexed

About

Beatrice Mahé is a scholar working on Hematology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Beatrice Mahé has authored 112 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Hematology, 46 papers in Pathology and Forensic Medicine and 44 papers in Genetics. Recurrent topics in Beatrice Mahé's work include Lymphoma Diagnosis and Treatment (45 papers), Chronic Lymphocytic Leukemia Research (32 papers) and Hematopoietic Stem Cell Transplantation (30 papers). Beatrice Mahé is often cited by papers focused on Lymphoma Diagnosis and Treatment (45 papers), Chronic Lymphocytic Leukemia Research (32 papers) and Hematopoietic Stem Cell Transplantation (30 papers). Beatrice Mahé collaborates with scholars based in France, Canada and United States. Beatrice Mahé's co-authors include Philippe Moreau, Nöel Milpied, Viviane Dubruille, Steven Le Gouill, Thomas Gastinne, Patrice Chevallier, Nadine Morineau, Jean‐Luc Harousseau, Thierry Guillaume and Nicolas Blin and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Beatrice Mahé

109 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Beatrice Mahé France	27	1.3k	1.2k	1.0k	897	499	112	2.8k
Francesco Lauria Italy	28	1.7k 1.3×	1.1k 0.9×	922 0.9×	1.0k 1.1×	870 1.7×	108	3.0k
John P. Greer United States	31	556 0.4×	1.5k 1.2×	914 0.9×	1.3k 1.5×	772 1.5×	119	3.3k
G.J. Ossenkoppele Netherlands	34	677 0.5×	812 0.7×	1.6k 1.5×	1.1k 1.3×	607 1.2×	84	3.3k
Alessandro Pulsoni Italy	30	1.2k 1.0×	2.1k 1.7×	858 0.8×	1.9k 2.2×	524 1.1×	143	4.5k
Krzysztof Warzocha Poland	26	999 0.8×	1.1k 0.9×	614 0.6×	672 0.7×	857 1.7×	169	2.6k
J L Harousseau France	22	815 0.6×	1.8k 1.5×	1.1k 1.1×	1.8k 2.0×	397 0.8×	36	3.3k
Isaac Ben‐Bassat Israel	34	816 0.6×	674 0.6×	1.3k 1.2×	587 0.7×	600 1.2×	140	3.2k
G. Verhoef Belgium	35	1.1k 0.9×	1.4k 1.1×	1.7k 1.6×	1.5k 1.6×	544 1.1×	103	4.4k
Réda Bouabdallah France	28	913 0.7×	1.9k 1.6×	1.5k 1.4×	2.0k 2.2×	577 1.2×	101	4.0k
Dolores Caballero Spain	36	1.1k 0.8×	2.0k 1.7×	1.7k 1.6×	1.8k 2.0×	1.1k 2.3×	137	4.5k

Countries citing papers authored by Beatrice Mahé

Since Specialization

Citations

This map shows the geographic impact of Beatrice Mahé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beatrice Mahé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beatrice Mahé more than expected).

Fields of papers citing papers by Beatrice Mahé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beatrice Mahé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beatrice Mahé. The network helps show where Beatrice Mahé may publish in the future.

Co-authorship network of co-authors of Beatrice Mahé

This figure shows the co-authorship network connecting the top 25 collaborators of Beatrice Mahé. A scholar is included among the top collaborators of Beatrice Mahé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beatrice Mahé. Beatrice Mahé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tomowiak, Cécile, Stéphanie Poulain, Pierre Feugier, et al.. (2024). Six-year follow-up of phase II study exploring chemo-free treatment association with idelalisib and obinutuzumab in symptomatic relapsed/ refractory patients with Waldenström’s macroglobulinemia. Annals of Hematology. 104(1). 685–690. 2 indexed citations

Tomowiak, Cécile, Stéphanie Poulain, Charles Herbaux, et al.. (2021). Obinutuzumab and idelalisib in symptomatic patients with relapsed/refractory Waldenström macroglobulinemia. Blood Advances. 5(9). 2438–2446. 21 indexed citations

Morio, Florent, Patrice Le Pape, Thomas Guimard, et al.. (2020). Ibrutinib, a Bruton's tyrosine kinase inhibitor, a new risk factor for cryptococcosis. Médecine et Maladies Infectieuses. 50(8). 742–745. 11 indexed citations

Bodet‐Milin, Caroline, Clément Bailly, Thierry Guillaume, et al.. (2018). Deauville Scores 4 or 5 Assessed by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Early Post-Allotransplant Is Highly Predictive of Relapse in Lymphoma Patients. Biology of Blood and Marrow Transplantation. 25(5). 906–911. 3 indexed citations

Tessoulin, Benoît, Thomas Gastinne, Philippe Moreau, et al.. (2017). Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/−R) is an effective treatment with low toxicity in Hodgkin’s and non-Hodgkin’s lymphomas. Annals of Hematology. 96(6). 943–950. 9 indexed citations

Péterlin, Pierre, Jacques Delaunay, Thierry Guillaume, et al.. (2014). Complete Donor T Cell Chimerism Predicts Lower Relapse Incidence after Standard Double Umbilical Cord Blood Reduced-Intensity Conditioning Regimen Allogeneic Transplantation in Adults. Biology of Blood and Marrow Transplantation. 21(1). 180–184. 10 indexed citations

Loirat, Marion, Patrice Chevallier, Christophe Leux, et al.. (2014). Upfront allogeneic stem-cell transplantation for patients with nonlocalized untreated peripheral T-cell lymphoma: an intention-to-treat analysis from a single center. Annals of Oncology. 26(2). 386–392. 30 indexed citations

Lok, Anne, et al.. (2014). Subcutaneous bortezomib incorporated into the bortezomib-thalidomide-dexamethasone regimen as part of front-line therapy in the context of autologous stem cell transplantation for multiple myeloma. Haematologica. 99(3). e33–e34. 12 indexed citations

Brion, A., Beatrice Mahé, Brigitte Kolb, et al.. (2011). Autologous transplantation in CLL patients with B and C Binet stages: final results of the prospective randomized GOELAMS LLC 98 trial. Bone Marrow Transplantation. 47(4). 542–548. 19 indexed citations

10.

Perić, Zinaida, Xavier Cahu, Patrice Chevallier, et al.. (2011). Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation. Leukemia. 25(6). 932–938. 57 indexed citations

11.

Voisin, Sophie, et al.. (2011). Acquired von Willebrand Syndrome Associated With Monoclonal Gammopathy. Medicine. 90(6). 404–411. 25 indexed citations

12.

Maloum, Karim, Catherine Settegrana, Élise Chapiro, et al.. (2009). IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide. Annals of Hematology. 88(12). 1215–1221. 23 indexed citations

13.

Salles, Gilles, Nicolas Mounier, Sophie de Guibert, et al.. (2008). Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study. Blood. 112(13). 4824–4831. 239 indexed citations

14.

Moreau, Philippe, Nöel Milpied, Beatrice Mahé, et al.. (1999). Melphalan 220 mg/m2 followed by peripheral blood stem cell transplantation in 27 patients with advanced multiple myeloma. Bone Marrow Transplantation. 23(10). 1003–1006. 76 indexed citations

15.

Hermouet, Sylvie, Danielle Pineau, Nelly Robillard, et al.. (1997). Analysis of platelet recovery after autologous transplantation with G-CSF mobilized CD34+ cells purified from leukapheresis products. PubMed. 39(6). 317–325. 12 indexed citations

16.

Mahé, Beatrice, Danielle Pineau, Nelly Robillard, Françoise Accard, & Sylvie Hermouet. (1996). Ex Vivo Expansion of Hematopoietic Progenitors from CD34+ Cells Selected from Leukapheresis Products of Lymphoma and Myeloma Patients: Feasibility and Enhancement by Fibronectin. Journal of Hematotherapy. 5(6). 671–679. 3 indexed citations

17.

Moreau, Philippe, Marie-France Kerguéris, Nöel Milpied, et al.. (1996). A pilot study of 220 mg/m² melphalan followed by autologous stem cell transplantation in patients with advanced haematological malignancies: pharmacokinetics and toxicity. British Journal of Haematology. 95(3). 527–530. 27 indexed citations

18.

Mahé, Beatrice, et al.. (1995). Occurrence of a T Cell Lymphoma in a Patient with Chronic Myeloid Leukemia Treated with Alpha Interferon. Leukemia & lymphoma. 19(5-6). 515–517. 1 indexed citations

19.

Moreau, Philippe, Jean‐Ralph Zahar, Nöel Milpied, et al.. (1993). Localized invasive pulmonary aspergillosis in patients with neutropenia. Effectiveness of surgical resection. Cancer. 72(11). 3223–3226. 43 indexed citations

20.

Moreau, Philippe, Nöel Milpied, Beatrice Mahé, et al.. (1993). Early Intensive Therapy with Autotransplantation for High-Risk Hodgkin's Disease. Leukemia & lymphoma. 12(1-2). 51–58. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact